Olugbenga Ogedegbe
Olugbenga Ogedegbe
Scroll
Professor of Social and Behavioral Sciences
Professor for the Department of Population Health at NYU Grossman School of Medicine
-
Professional overview
-
Gbenga Ogedegbe, a physician, is Professor of Population Health & Medicine, Chief Division of Health & Behavior and Director Center for Healthful Behavior Change in the Department of Population Health at the School of Medicine. Gbenga is a leading expert on health disparities research; his work focuses on the implementation of evidence-based interventions for cardiovascular risk reduction in minority populations. He is Principal Investigator on numerous NIH projects, and has expanded his work globally to Sub-Saharan Africa where he is funded by the NIH to strengthen research capacity and reduce the burden of noncommunicable diseases. He has co-authored over 250 publications and his work has been recognized by receipt of several research and mentoring awards including the prestigious John M. Eisenberg Excellence in Mentorship Award from the Agency for Healthcare Research and Quality, and the Daniel Savage Science Award. He has served on numerous scientific panels including the NIH, CDC, World Health Organization, and the European Union Research Council. Prior to joining NYU, he was faculty at Cornell Weill Medical School and Columbia University College of Physicians and Surgeons.
-
Education
-
MPH from Columbia University, 1999Residency, Montefiore Medical Center, Internal Medicine, 1998MD from Donetsk University, 1988
-
Areas of research and study
-
Access to HealthcareGlobal HealthHealth of Marginalized PopulationImplementation and Impact of Public Health RegulationsImplementation scienceStroke and Cardiovascular Disease
-
Publications
Publications
Results from the trial using motivational interviewing, positive affect, and self-affirmation in African Americans with hypertension (TRIUM PH)
Sex Disparity in Blood Pressure Levels Among Nigerian Health Workers
Social and behavioral predictors of insufficient sleep among African Americans and Caucasians
Tailored Approach to Sleep Health Education (TASHE): A Community-engaged, Multiple-Stakeholder-Informed Project to Promote Awareness of Sleep Apnea Among Blacks
Robbins, R., Rapoport, D. M., Allegrante, J. P., Cohall, A. T., Ogedegbe, O., Williams, N. J., Newsome, V., & Jean-Louis, G. (n.d.).Publication year
2016Journal title
TrialsTesting the use of practice facilitation in a cluster randomized stepped-wedge design trial to improve adherence to cardiovascular disease prevention guidelines: HealthyHearts NYC
The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries
W.Tobe, S., Attaran, A., De Villiers, A., Featherstone, A., Forrest, J., Kalyesubula, R., Kamwesiga, J., Kengne, A. P., Lopez, P. C., Mills, E., Mukasa, B., Muldoon, K., Tayari, J. C., Yaya, S., Kien Keat, N., Lopez, P., Casas, J. L., McCready, T., McKee, M., … Warth, S. (n.d.).Publication year
2016Journal title
Journal of Clinical HypertensionVolume
18Issue
7Page(s)
600-605Toward the sustainability of health interventions implemented in sub-Saharan Africa: A systematic review and conceptual framework
Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement
AbstractRosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., De Lemos, J. A., Elliott, W. J., Findeiss, L., Gersh, B. J., Gore, J. M., Levy, D., Long, J. B., O’Connor, C. M., O’Gara, P. T., Ogedegbe, O., Oparil, S., & White, W. B. (n.d.).Publication year
2016Journal title
American Journal of MedicineVolume
129Issue
4Page(s)
372-378AbstractThe 2015 American Heart Association/American College of Cardiology/American Society of Hypertension Scientific Statement "Treatment of Hypertension in Patients with Coronary Artery Disease" is summarized in the context of a clinical case. The Statement deals with target blood pressures, and the optimal agents for the treatment of hypertension in patients with stable angina, in acute coronary syndromes, and in patients with ischemic heart failure. In all cases, the recommended blood pressure target is <140/90 mm Hg, but <130/80 mm Hg may be appropriate, especially in those with a history of a previous myocardial infarction or stroke, or at high risk for developing either. These numbers may need to be revised after the publication of the SPRINT data. Appropriate management should include beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and in the case of heart failure, aldosterone antagonists. Thiazide or thiazide-like (chlorthalidone) diuretics and calcium channel blockers can be used for the management of hypertension, but the evidence for improved outcomes compared with other agents in hypertension with coronary artery disease is meager. Loop diuretics should be reserved for patients with New York Heart Association Class III and IV heart failure or with a glomerular filtration rate of <30 mL/min.Uncontrolled blood pressure and risk of sleep apnea among blacks: Findings from the metabolic syndrome outcome (MetSO) study
Using Qualitative Methods to Assess the Conceptual Equivalence of the Spanish and English Stroke Action Test (STAT)
White-Coat Effect Among Older Adults: Data From the Jackson Heart Study
A Concept Mapping Study of Physicians' Perceptions of Factors Influencing Management and Control of Hypertension in Sub-Saharan Africa
A Global Perspective on Cardiovascular Disease in Vulnerable Populations
A narrative synthesis of the health systems factors influencing optimal hypertension control in Sub-Saharan Africa
Associations of Short Sleep and Shift Work Status with Hypertension among Black and White Americans
Behaviour change strategies for reducing blood pressure-related disease burden: Findings from a global implementation research programme
AbstractPeiris, D., Thompson, S. R., Beratarrechea, A., Cárdenas, M. K., Diez-Canseco, F., Goudge, J., Gyamfi, J., Kamano, J. H., Irazola, V., Johnson, C., Kengne, A. P., Keat, N. K., Miranda, J. J., Mohan, S., Mukasa, B., Ng, E., Nieuwlaat, R., Ogedegbe, O., Ovbiagele, B., … Uvere, E. (n.d.).Publication year
2015Journal title
Implementation ScienceVolume
10Issue
1AbstractBackground: The Global Alliance for Chronic Diseases comprises the majority of the world's public research funding agencies. It is focussed on implementation research to tackle the burden of chronic diseases in low- and middle-income countries and amongst vulnerable populations in high-income countries. In its inaugural research call, 15 projects were funded, focussing on lowering blood pressure-related disease burden. In this study, we describe a reflexive mapping exercise to identify the behaviour change strategies undertaken in each of these projects. Methods: Using the Behaviour Change Wheel framework, each team rated the capability, opportunity and motivation of the various actors who were integral to each project (e.g. community members, non-physician health workers and doctors in projects focussed on service delivery). Teams then mapped the interventions they were implementing and determined the principal policy categories in which those interventions were operating. Guidance was provided on the use of Behaviour Change Wheel to support consistency in responses across teams. Ratings were iteratively discussed and refined at several group meetings. Results: There was marked variation in the perceived capabilities, opportunities and motivation of the various actors who were being targeted for behaviour change strategies. Despite this variation, there was a high degree of synergy in interventions functions with most teams utilising complex interventions involving education, training, enablement, environmental restructuring and persuasion oriented strategies. Similar policy categories were also targeted across teams particularly in the areas of guidelines, communication/marketing and service provision with few teams focussing on fiscal measures, regulation and legislation. Conclusions: The large variation in preparedness to change behaviour amongst the principal actors across these projects suggests that the interventions themselves will be variably taken up, despite the similarity in approaches taken. The findings highlight the importance of contextual factors in driving success and failure of research programmes. Forthcoming outcome and process evaluations from each project will build on this exploratory work and provide a greater understanding of factors that might influence scale-up of intervention strategies.Blood Pressure Visit Intensification Study in Treatment: Trial design
AbstractFiscella, K., Ogedegbe, G., He, H., Carroll, J., Cassells, A., Sanders, M., Khalida, C., D’Orazio, B., & Tobin, J. N. (n.d.).Publication year
2015Journal title
American Heart JournalVolume
170Issue
6Page(s)
1202-1210AbstractBackground There is a presumption that, for patients with uncontrolled blood pressure (BP), early follow-up, that is, within 4 weeks of an elevated reading, improves BP control. However, data are lacking regarding effective interventions for increasing clinician frequency of follow-up visits and whether such interventions improve BP control. Methods/design Blood Pressure Visit Intensification Study in Treatment involves a multimodal approach to improving intensity of follow-up in 12 community health centers using a stepped wedge study design. Discussion The study will inform effective interventions for increasing frequency of follow-up visits among patients with uncontrolled BP and determine whether increasing follow-up frequency is associated with better BP control.Claim Your Space: Leadership Development as a Research Capacity Building Goal in Global Health
Community programs for hypertension
Comparative effectiveness of angiotensin-converting enzyme inhibitor-based treatment on cardiovascular outcomes in hypertensive blacks versus whites
Comparative effectiveness of home blood pressure telemonitoring (HBPTM) plus nurse case management versus HBPTM alone among Black and Hispanic stroke survivors: Study protocol for a randomized controlled trial
AbstractSpruill, T. M., Williams, O., Teresi, J. A., Lehrer, S., Pezzin, L., Waddy, S. P., Lazar, R. M., Williams, S. K., Jean-Louis, G., Ravenell, J., Penesetti, S., Favate, A., Flores, J., Henry, K. A., Kleiman, A., Levine, S. R., Sinert, R., Smith, T. Y., Stern, M., … Ogedegbe, G. (n.d.).Publication year
2015Journal title
TrialsVolume
16Issue
1AbstractBackground: Black and Hispanic stroke survivors experience higher rates of recurrent stroke than whites. This disparity is partly explained by disproportionately higher rates of uncontrolled hypertension in these populations. Home blood pressure telemonitoring (HBPTM) and nurse case management (NCM) have proven efficacy in addressing the multilevel barriers to blood pressure (BP) control and reducing BP. However, the effectiveness of these interventions has not been evaluated in stroke patients. This study is designed to evaluate the comparative effectiveness, cost-effectiveness and sustainability of these two telehealth interventions in reducing BP and recurrent stroke among high-risk Black and Hispanic stroke survivors with uncontrolled hypertension. Methods/Design: A total of 450 Black and Hispanic patients with recent nondisabling stroke and uncontrolled hypertension are randomly assigned to one of two 12-month interventions: 1) HBPTM with wireless feedback to primary care providers or 2) HBPTM plus individualized, culturally-tailored, telephone-based NCM. Patients are recruited from stroke centers and primary care practices within the Health and Hospital Corporations (HHC) Network in New York City. Study visits occur at baseline, 6, 12 and 24 months. The primary outcomes are within-patient change in systolic BP at 12 months, and the rate of stroke recurrence at 24 months. The secondary outcome is the comparative cost-effectiveness of the interventions at 12 and 24 months; and exploratory outcomes include changes in stroke risk factors, health behaviors and treatment intensification. Recruitment for the stroke telemonitoring hypertension trial is currently ongoing. Discussion: The combination of two established and effective interventions along with the utilization of health information technology supports the sustainability of the HBPTM + NCM intervention and feasibility of its widespread implementation. Results of this trial will provide strong empirical evidence to inform clinical guidelines for management of stroke in minority stroke survivors with uncontrolled hypertension. If effective among Black and Hispanic stroke survivors, these interventions have the potential to substantially mitigate racial and ethnic disparities in stroke recurrence. Trial registration: ClinicalTrials.gov NCT02011685. Registered 10 December 2013.Designing and evaluating health systems level hypertension control interventions for African-Americans: Lessons from a pooled analysis of three cluster randomized trials
AbstractPavlik, V. N., Chan, W., Hyman, D. J., Feldman, P., Ogedegbe, G., Schwartz, J. E., McDonald, M., Einhorn, P., & Tobin, J. N. (n.d.).Publication year
2015Journal title
Current Hypertension ReviewsVolume
11Issue
2Page(s)
123-131AbstractObjectives: African-Americans (AAs) have a high prevalence of hypertension and their blood pressure (BP) control on treatment still lags behind other groups. In 2004, NHLBI funded five projects that aimed to evaluate clinically feasible interventions to effect changes in medical care delivery leading to an increased proportion of AA patients with controlled BP. Three of the groups performed a pooled analysis of trial results to determine: 1) the magnitude of the combined intervention effect; and 2) how the pooled results could inform the methodology for future health-system level BP interventions. Methods: Using a cluster randomized design, the trials enrolled AAs with uncontrolled hypertension to test interventions targeting a combination of patient and clinician behaviors. The 12-month Systolic BP (SBP) and Diastolic BP (DBP) effects of intervention or control cluster assignment were assessed using mixed effects longitudinal regression modeling. Results: 2,015 patients representing 352 clusters participated across the three trials. Pooled BP slopes followed a quadratic pattern, with an initial decline, followed by a rise toward baseline, and did not differ significantly between intervention and control clusters: SBP linear coefficient = -2.60±0.21 mmHg per month, p<0.001; quadratic coefficient = 0.167± 0.02 mmHg/month, p<0.001; group by time interaction group by time group x linear time coefficient=0.145 ± 0.293, p=0.622; group x quadratic time coefficient= -0.017 ± 0.026, p=0.525). Results were similar for DBP. The individual sites did not have significant intervention effects when analyzed separately. Conclusion: Investigators planning behavioral trials to improve BP control in health systems serving AAs should plan for small effect sizes and employ a “run-in” period in which BP can be expected to improve in both experimental and control clusters.Differential increase in prevalence estimates of inadequate sleep among black and white Americans
Effect of a congregation-based intervention on uptake of HIV testing and linkage to care in pregnant women in Nigeria (Baby Shower): A cluster randomised trial
Ethical oversight in quality improvement and quality improvement research: New approaches to promote a learning health care system Ethics in Biomedical Research